Univest
Univest
  • Markets

Apollo Hospitals Enterprise (APOLLOHOSP) Share Price Falls for Second Straight Session

  • September 30, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Apollo Hospitals Enterprise Share Price Fall Streak
Apollo Hospitals Enterprise (APOLLOHOSP) share price fell to Rs 8,514 today, down 2.16% from the previous close. Market cap was Rs 1,27,421.96 crore.

Apollo Hospitals Enterprise Share Price Fall Streak extended to a second straight session, with the stock closing lower again and taking the two-session decline to 3.93% from the streak base of Rs 8,862. The latest close was Rs 8,514, and the move is confirmed by Univest data without a company-specific catalyst. This is now a short sequence of lower closes rather than a one-day dip.

The company’s market capitalisation stood at Rs 1,27,421.96 crore, keeping Apollo Hospitals Enterprise Share Price Fall Streak in the large-cap bracket. For readers tracking Apollo Hospitals Enterprise Share Price, the important point is that back-to-back lower closes change the reading of the move: the decline is now cumulative, not isolated, and the lower price base affects how the stock is viewed across the rest of the article.

Table of Contents

Toggle
  • What the Consecutive Declines Show
  • Apollo Hospitals Enterprise (APOLLOHOSP) Share Price Fall Streak: Consecutive Decline Analysis
  • Apollo Hospitals Enterprise (APOLLOHOSP) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Apollo Hospitals Enterprise
  • About Apollo Hospitals Enterprise
  • Track Apollo Hospitals Enterprise Share Price on Univest
  • Frequently Asked Questions
    • Why is Apollo Hospitals Enterprise Share Price falling today?
    • What does the Apollo Hospitals Enterprise Share Price fall streak mean?
    • What is Apollo Hospitals Enterprise Share Price today?
    • How large is Apollo Hospitals Enterprise in market capitalisation terms?
    • How is Apollo Hospitals Enterprise valued versus the healthcare benchmark?
    • What do ROE and ROCE say about Apollo Hospitals Enterprise Share Price?
    • How do EPS and book value support the Apollo Hospitals Enterprise Share Price view?
    • How does Apollo Hospitals Enterprise compare with healthcare peers?

What the Consecutive Declines Show

Apollo Hospitals Enterprise Share Price Fall Streak now reflects two lower closes in a row, which makes the weakness more meaningful than a single-session slip. The first session began the move from Rs 8,862, and the latest close deepened the total decline to 3.93%. That tells readers the stock is being repriced across consecutive sessions, not just reacting to one intraday move.

The streak matters because the same business and the same reported fundamentals are now being assessed at a lower trading level. Apollo Hospitals Enterprise Share Price remains the same large healthcare franchise, but the pattern of lower closes has shifted the market’s short-term reading. According to Univest data, the decline is verified, while no company-specific cause is established. Apollo Hospitals Enterprise Share Price Fall Streak is therefore best read as a price pattern first and a business question second.

Apollo Hospitals Enterprise (APOLLOHOSP) Share Price Fall Streak: Consecutive Decline Analysis

Metric Value
Current Price Rs 8,514
Previous Close Rs 8,701.9
Today's Move -Rs 187.90 (-2.16%)
Open Rs 8,699.75
High Rs 8,699.75
Low Rs 8,493.15
Market Capitalisation Rs 1,27,421.96 crore

Apollo Hospitals Enterprise (APOLLOHOSP) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,27,421.96 crore
P/E Ratio 59.88x
P/B Ratio 12.92x
ROE 23.54%
ROCE 21.73%
EPS Rs 145.32
Book Value Per Share Rs 673.58
Dividend Yield 0.23%

Apollo Hospitals Enterprise Share Price Fall Streak does not change earnings, book value or profitability on its own, but it does reduce the price base used for valuation. The stock trades on a P/E of 59.88 and a P/B of 12.92, with ROE at 23.54% and ROCE at 21.73%. EPS stands at Rs 145.32, book value per share at Rs 673.58 and dividend yield at 0.23%.

Those numbers show why Apollo Hospitals Enterprise Share Price continues to be watched closely after the decline. The current fall places the stock against a high valuation backdrop, while the profitability ratios remain strong. Apollo Hospitals Enterprise Share Price Fall Streak therefore sits at the intersection of premium pricing and lower market levels, which makes the latest move relevant even without a fresh catalyst.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 59.88x
Benchmark Median P/E 46.9x
Benchmark Average P/E 100.02x
Benchmark P/E Range 6.8x to 1,572.9x
Company P/B Ratio 12.92x
Benchmark Median P/B 3.88x
Benchmark Average P/B 4.71x
Company ROE 23.54%
Benchmark Median ROE 13.01%
Benchmark Average ROE 12.87%
Company ROCE 21.73%
Benchmark Median ROCE 15.84%
Benchmark Average ROCE 2.83%
Company Market Capitalisation Rs 1,27,421.96 crore
Benchmark Median Market Cap Rs 578.29 crore
Benchmark Average Market Cap Rs 11,352.34 crore

Apollo Hospitals Enterprise Share Price Fall Streak needs to be read within Healthcare, specifically the Hospital & Healthcare Services industry. In the same-industry benchmark of 65 companies, Apollo Hospitals Enterprise carries a P/E of 59.88 versus a median of 46.9 and an average of 100.02. Its P/B of 12.92 is well above the median of 3.88 and the average of 4.71.

Return ratios remain above the benchmark too. Apollo Hospitals Enterprise reports ROE of 23.54% against a median of 13.01% and ROCE of 21.73% against a median of 15.84%. Its market capitalisation of Rs 1,27,421.96 crore is far above the benchmark median of Rs 578.29 crore and the benchmark average of Rs 11,352.34 crore. The sector backdrop therefore shows a large premium-valued healthcare name, and Apollo Hospitals Enterprise Share Price Fall Streak is a move within that premium band, not a shift into a low-multiple setup.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Max Healthcare Institute MAXHEALTH 97,418.62 65.73 8.76 14.53 14.97
MANIPAL HEALTH ENTERPRI L MANIPALHOS 94,970.23 110.4 5.4 12.95 13.93
Aster DM Healthcare ASTERDM 65,183.66 201.12 15.15 13.07 16.22
Fortis Healthcare FORTIS 62,782.32 59.01 6.08 11.32 14.07
Global Health MEDANTA 38,551.27 68.43 9.26 15.12 19.38

Apollo Hospitals Enterprise Share Price Fall Streak also looks strong on size relative to the peers shown. Max Healthcare Institute has a market cap of Rs 97,418.62 crore, Manipal Health Enterpri L has Rs 94,970.23 crore, Aster DM Healthcare has Rs 65,183.66 crore, Fortis Healthcare has Rs 62,782.32 crore and Global Health has Rs 38,551.27 crore. Apollo Hospitals Enterprise remains the largest of the listed group.

On valuation, Apollo Hospitals Enterprise shares a similar P/E range with some peers but remains more expensive on P/B than several of them. Its P/E of 59.88 is close to Fortis Healthcare at 59.01 and below Max Healthcare at 65.73, while its ROE of 23.54% is stronger than the listed peers in this snapshot. Apollo Hospitals Enterprise Share Price Fall Streak has not altered its size leadership, but it has kept the stock in a premium valuation band relative to the peer set.

Why Investors Are Watching Apollo Hospitals Enterprise

Apollo Hospitals Enterprise Share Price Fall Streak matters because it is now a two-session decline rather than an isolated move. The stock closed at Rs 8,514, below the previous close of Rs 8,701.9, and the cumulative fall from the streak base is 3.93%. That makes the pattern important even without a verified trigger.

  • Apollo Hospitals Enterprise Share Price Fall Streak has extended to a second straight session.
  • The latest close remained below the previous close, keeping the tone negative.
  • P/E of 59.88 and P/B of 12.92 keep valuation central to the read.
  • ROE of 23.54% and ROCE of 21.73% remain important context after the decline.
  • The stock stays in the large-cap category with a market capitalisation of Rs 1,27,421.96 crore.

About Apollo Hospitals Enterprise

Apollo Hospitals Enterprise operates in the Hospital & Healthcare Services industry within Healthcare. For Apollo Hospitals Enterprise Share Price Fall Streak, the business backdrop matters because the company is part of a large, established healthcare platform rather than a cyclical commodity name. Investors generally read Apollo Hospitals Enterprise Share Price through healthcare demand, service mix and profitability ratios.

The company sits in a sector where scale and return ratios matter, and that is why Apollo Hospitals Enterprise Share Price remains a premium-marketcap stock even after the latest decline. Apollo Hospitals Enterprise Share Price Fall Streak should therefore be understood as a market-pricing event layered on top of a large healthcare franchise with strong return metrics.

Track Apollo Hospitals Enterprise Share Price on Univest

Use Apollo Hospitals Enterprise (APOLLOHOSP) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Apollo Hospitals Enterprise Share Price Fall Streak can be followed on Univest alongside key valuation ratios, profitability metrics and peer comparison. Apollo Hospitals Enterprise Share Price is also easy to track with live updates and market context in one place.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Apollo Hospitals Enterprise Share Price falling today?

Ans. Apollo Hospitals Enterprise Share Price is lower for a second straight session, but the verified price data does not establish a company-specific cause. The stock traded at Rs 8,514 versus the previous close of Rs 8,701.9.

What does the Apollo Hospitals Enterprise Share Price fall streak mean?

Ans. Apollo Hospitals Enterprise Share Price Fall Streak means the stock has closed lower in two consecutive sessions. The cumulative decline from the streak base of Rs 8,862 is 3.93%, which gives the move more context than a single-day fall.

What is Apollo Hospitals Enterprise Share Price today?

Ans. Apollo Hospitals Enterprise Share Price was Rs 8,514 in the latest session. That compares with the previous close of Rs 8,701.9 and reflects a day change of Rs 187.9, or 2.16% lower.

How large is Apollo Hospitals Enterprise in market capitalisation terms?

Ans. Apollo Hospitals Enterprise has a market capitalisation of Rs 1,27,421.96 crore. That places Apollo Hospitals Enterprise Share Price in the large-cap category and far above the healthcare benchmark median shown in the sector snapshot.

How is Apollo Hospitals Enterprise valued versus the healthcare benchmark?

Ans. Apollo Hospitals Enterprise Share Price carries a P/E of 59.88 and a P/B of 12.92. Against the same-industry median P/E of 46.9 and median P/B of 3.88, the stock remains valued at a premium.

What do ROE and ROCE say about Apollo Hospitals Enterprise Share Price?

Ans. Apollo Hospitals Enterprise reports ROE of 23.54% and ROCE of 21.73%. Those ratios sit above the industry medians in the snapshot, which helps provide context for Apollo Hospitals Enterprise Share Price even after the decline.

How do EPS and book value support the Apollo Hospitals Enterprise Share Price view?

Ans. EPS is Rs 145.32 and book value per share is Rs 673.58. These figures help explain the earnings and accounting base behind Apollo Hospitals Enterprise Share Price, while the current price sets the valuation multiples.

How does Apollo Hospitals Enterprise compare with healthcare peers?

Ans. Apollo Hospitals Enterprise Share Price is larger than the peer set shown on market capitalisation and has a P/E close to Fortis Healthcare. It also shows stronger ROE than the listed peers in this snapshot.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply